Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Steadymed Ltd Ord Sh (STDY)

Steadymed Ltd Ord Sh (STDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Steadymed Ltd Ord Sh 5 OPPENHEIMER STREET REHOVOT L3 7670105 ISR

www.steadymed.com P: 925-272-4999

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

SteadyMed Ltd. is a specialty pharmaceutical company which focused on the development of drug products to treat orphan and other diseases. The company's lead candidate consist of Trevyent(R), a development stage drug product which utilizes SteadyMed's PatchPump(R) technology to treat pulmonary arterial hypertension. SteadyMed Ltd. is headquartered in San Ramon, California.

Key Statistics

Overview:

Market Capitalization, $K 126,347
Shares Outstanding, K 26,740
% of Insider Shareholders 38.63%
% of Institutional Shareholders 43.76%

Financials:

Annual Sales, $ 1,070 K
Annual Net Income, $ -23,210 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,360 K

Growth:

1-Year Return -23.81%
3-Year Return 23.37%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/12/18
Earnings Per Share ttm -0.96
EPS Growth vs. Prev Qtr 2.56%
EPS Growth vs. Prev Year -15.15%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

STDY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -94.69%
Return-on-Assets % -47.15%
Profit Margin % -2,169.16%
Debt/Equity 0.00
Price/Sales 119.28
Price/Cash Flow N/A
Price/Book 29.19
Book Value/Share -0.52
Interest Coverage -7.41
60-Month Beta 0.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.